Simmons Jeffrey N 4
4 · Elanco Animal Health Inc · Filed Jan 27, 2026
Research Summary
AI-generated summary of this filing
ELAN CEO Jeffrey Simmons Receives 113 Deferred Stock Units
What Happened Jeffrey N. Simmons, President, CEO and Director of Elanco Animal Health Inc. (ELAN), was granted 113.493 deferred stock units on January 23, 2026. The award is recorded at $24.40 per unit for a total value of approximately $2,769. This was an award/grant (derivative), not an open‑market purchase or sale.
Key Details
- Transaction date: 2026-01-23; Grant/Award (code A)
- Grant terms recorded at $24.40 per unit; total reported value ≈ $2,769
- Units granted: 113.493 deferred stock units (DSUs)
- Shares owned after the transaction: not disclosed in this filing
- Filing date / timeliness: Form 4 filed 2026-01-27 (timely relative to the report date)
- Footnotes:
- F1: Each deferred stock unit represents the right to receive one share of common stock or the cash equivalent.
- F2: DSUs settle in cash or shares following termination of employment or during a specified future year under the company’s Executive Deferral and Stock Match Plan.
Context Deferred stock units are a form of long‑term compensation that do not result in immediate share ownership; they convert to shares or cash at a later date per plan rules. Such awards are typically routine executive compensation and should be viewed as compensation-related rather than a direct market buy/sell signal.
Insider Transaction Report
- Award
Deferred Stock Units
[F1][F2]2026-01-23$24.40/sh+113.493$2,769→ 18,959.015 total→ Common Stock (113.493 underlying)
Footnotes (2)
- [F1]Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
- [F2]Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.